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ABSTRACT
Objective: This study aimed to develop and validate an analytical method using thin-layer chromatography (TLC)-densitometry for detecting the 
presence of glibenclamide and metformin hydrochloride in herbal diabetic products.
Methods: The jamu samples were extracted using methanol, followed by analysis using TLC-densitometry with methanol-aquades-glacial acetic acid 
(9:1:0.25) as the mobile phase at a wavelength of 237 nm.
Results: From the validation results, the correlation coefficients for glibenclamide and metformin hydrochloride were determined to be 0.9998 
and 0.9981, respectively. The limits of detection and quantitation for glibenclamide were 49.97 µg/mL and 66.55 µg/mL, respectively, while those 
of metformin hydrochloride were 74.75 µg/mL and 249.25 µg/mL, respectively. The method developed in this study met the criteria of selectivity, 
accuracy, and precision. From seven jamu samples tested, four tested positive for glibenclamide, with sample 1=4.9522%, sample 2=4.1495%, sample 
3=4.2578%, and sample 4=4.9412%.
Conclusion: None of the jamu samples contained metformin hydrochloride.
Keywords: Glibenclamide, Metformin hydrochloride, Optimization, Thin-layer chromatography densitometry, Validation.
INTRODUCTION
Traditional medicine has been widely used by Indonesian people since 
ancient times. It can be used in the treatment of diseases, as well as part 
of an overall strategy for disease prevention and health optimization. 
Traditional medicines are substances or formulas of substances 
in the form of herbal mixes, animal compounds, minerals, essence 
preparations (galenic), or a mixture thereof, and have been used from 
generation to generation for treatments based on experience [1]. The 
use of traditional medicine is generally preferred over that of synthetic 
drugs, also known as modern medicine. The side effects of traditional 
medicines are considered fewer than in those of modern medicine such 
that traditional medicine is said to be safer than modern medicine [2]. 
However, in Indonesia, many traditional medicines have been found to 
contain medicinal chemicals that are harmful to human health.
In November 2015, the BPOM announced 50 traditional medicines 
and food supplements that were considered harmful because they 
contained medicinal chemicals. The medicinal chemicals that have 
been found in traditional medicines and food supplements include 
paracetamol, caffeine, tadalafil, and sildenafil citrate [1]. However, 
according to the Republic of Indonesia Indonesian Minister of Health 
Regulation No. 007 (2012) concerning the Registration of Traditional 
Medicines, traditional medicines are prohibited to contain medicinal 
chemicals, which are the result of isolation or synthetic preparation and 
have medicinal properties [3].
One example of a traditional medicine commonly consumed by 
Indonesian people is jamu. Several studies have reported the discovery 
of medicinal chemicals in herbal medicines, including the addition 
of corticosteroid hormones in jamu for aching pain [4]. In addition, 
using thin-layer chromatography (TLC)-densitometry, mefenamic acid, 
paracetamol, and ibuprofen have been found to be present in jamu 
formulations used for gout [5]. Accordingly, many herbal formulations 
that have not been studied remain, including jamu for diabetes. While 
a medicinal chemical analysis was performed on jamu for diabetes by 
Jayanti et al. in 2015, the method was only performed qualitatively [6].
Therefore, the development of an analytical method for determining the 
presence of chemical drugs in jamu for diabetes by TLC-densitometry, 
both qualitatively and quantitatively, is needed. In addition, it is important 
to determine the limits of detection (LOD) of chemical drugs in jamu 
samples. It is expected that the LOD of analytes in jamu samples may give 
better results than those found in the previous studies. This study was 
also conducted to determine if there are dangerous levels of medicinal 
chemicals present in jamu samples. The compounds we analyzed for 
were glibenclamide and metformin hydrochloride, which are common 
drugs used in the treatment of diabetes. TLC-densitometry was chosen as 
the best method because it uses simple equipment, the mobile phase is 
relatively inexpensive, and it can quickly analyze for compounds in jamu.
METHODS
The materials used were the drugs glibenclamide (PT. Indofarma 
Tbk, Indonesia) and metformin hydrochloride (PT. Dexa Medica Tbk, 
Indonesia); chemicals in the form of aquades (Merck, Germany), 
methanol p.a (Merck), toluene p.a (Merck), glacial acetic acid p.a 
(Merck), ammonia 25% p.a (Merck), and ethyl acetate p.a (Merck). The 
samples analyzed were seven samples of jamu for diabetes, consisting 
of three samples of branded jamu (samples MX, CR, and NE) and four 
samples of concoction jamu (samples BI, SU, SP, and LN), which were 
obtained from the stores in Tangerang, Indonesia.
The spots obtained after TLC were analyzed using densitometer (Camag 
TLC Scanner 3), a computer connected to a scanner and equipped with 
“Wincats” applications, chamber chromatography, sonicators, TLC 
Silica gel 60 F254 plates, UV Cabinet, volume pipettes, capillary pipes, 
Whatman® grade 41 filter paper, and glassware.
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Preparation of standard solution
To prepare the glibenclamide standard solution, a total of 10 mg of 
glibenclamide was weighed and placed into a 10 mL volumetric flask; 
methanol was then added to the volume limit to obtain a standard 
solution concentration of 1 mg/mL (1000 µg/mL). Similarly, to 
prepare the metformin hydrochloride standard solution, a total of 
10 mg metformin hydrochloride was weighed and placed into a 10 mL 
volumetric flask; methanol was then added to the volume limit to obtain 
a standard solution concentration of 1 mg/mL (1000 µg/mL).
Preparation of sample solution
A single dose sample of each herbal formulation was weighed and 
placed into a mortar and crushed until homogeneous. A total of 350 mg 
(or equal to 1/20 of the jamu weight) was weighed carefully and placed 
into a 10 mL volumetric flask; methanol was then added to represent 
half of the solvent. The mixture was then shaken until homogeneous, 
sonicated until dissolved, and methanol added to the volume limit.
Preparation of sample solutions that adduct with drug compounds
A single dose sample for each herbal formulation was weighed and 
placed into a mortar and crushed until homogeneous. A total of 350 mg 
(or equal to 1/20 of the jamu weight) was weighed carefully and placed 
into a 10 mL volumetric flask; methanol was then added to represent 
half of the solvent. The mixture was then shaken until homogeneous 
and sonicated until dissolved. Two milliliters each of the standard 
solutions of glibenclamide (1000 µg/mL) and metformin hydrochloride 
(1000 µg/mL) were then added to sufficient volume.
Mobile phase selection
This experiment was conducted using 2 µL glibenclamide and 
metformin hydrochloride standard solutions on the TLC plate, followed 
by elution with the mobile phase that had been used in the previous 
studies with an elution limit of up to 9 cm. A mobile phase that could 
separate the four compounds well and had a retention factor (Rf) range 
of 0.2–0.8 (Table 1) was chosen.
Optimum wavelength optimization
From the solution made for mobile phase optimization, repeated 
analysis using densitometry at the wavelength of each drug compound 
based on the literature was performed [7,8]. The optimal wavelength 
that could analyze each compound by providing the largest area 
(Table 2) was selected.
Extraction system optimization
A total of 350 mg (or equal to 1/20 of the jamu kosong weight) 
was weighed carefully and placed into a 10 mL volumetric flask; 
approximately 2.0 mL of glibenclamide solution was added to sufficient 
volume. The same procedure was performed with the metformin 
hydrochloride solution. To separate the insoluble particles, filtration 
and precipitation were performed for 5 min. Then, the filtrate, 
supernatant, and standard solution were dropped on one TLC plate and 
eluted with the selected mobile phase. A separation method that would 




Specificity and selectivity tests were performed by comparing the 
results of the analyses of the jamu solutions that did not contain 
medicinal chemicals, the jamu solution that drug compounds were 
added, and standard solutions. The method was considered selective, 
if there was no spotting for the jamu solution that did not contain 
the medicinal chemicals at the Rf for each standard solution and the 
adducted jamu solution.
Linearity and calibration curves
A total of 250 mg standard glibenclamide was weighed and placed into 
a 25 mL volumetric flask; a sufficient volume of methanol was then 
added to mark the boundary so that a standard solution concentration 
of 10,000 µg/mL was obtained. Aliquots of the solution were pipetted 
sequentially at 0.5, 1, 1.5, 2, 2.5, and 3 mL into a 10 mL volumetric flask; 
a sufficient volume of methanol was then added to mark the boundary 
so that concentrations of 500 µg/mL, 1000 mg/mL, 1500 mg/mL, 
2000 mg/mL, 2500 mg/mL, and 3000 mg/mL were obtained.
A total of 100 mg standard metformin hydrochloride was weighed and 
placed into a 50 mL volumetric flask; a sufficient volume of methanol 
was then added to mark the boundary so that a standard solution 
concentration of 2000 µg/mL was obtained. Aliquots of the solution were 
pipetted sequentially at 3, 4, 5, 6, 7, and 8 mL into a 10 mL volumetric 
flask; a sufficient volume of methanol was then added to mark the 
boundary so that concentrations of 600 µg/mL, 800 µg/mL, 1000 
µg/mL, 1200 µg/mL, 1400 µg/mL, and 1600 µg/mL were obtained.
Each solution was then dropped as much as 2 µL onto the TLC plate 
and analyzed.
LOD and limit of quantitation (LOQ)
From the calibration curve data, the LOD and LOQ were calculated. LOD 
and LOQ values were calculated by measuring the replicates of the blank 
sample and calculating the mean result and the standard deviation.
Accuracy and precision
Accuracy and precision tests were performed by diluting the standard 
solution of glibenclamide (10,000 µg/mL) and metformin hydrochloride 
(2000 µg/mL) to obtain solutions of three different concentrations.
Accuracy and precision tests for the standard solution of glibenclamide 
were performed at concentrations of 3500 µg/mL, 2000 µg/mL, and 
500 µg/mL. For the standard solution of metformin hydrochloride, 
accuracy and precision tests were performed at concentrations of 
1600 µg/mL, 1200 µg/mL, and 600 µg/mL. Each solution was put into 
a total of 350 mg (or equal to 1/20 the dosage) of the blank matrix that 
did not contain any medicinal ingredients and then dropped onto the 
TLC plate as much as six drops. The mixture was then eluted with the 
selected mobile phase. We calculated the percent recovery by entering 
the area data obtained from the TLC-densitometry analysis. Standard 
deviation values and the coefficient of variation were calculated from 
data obtained from the accuracy analysis.
Qualitative analysis of medicinal compounds in jamu
A total of 350 mg of the jamu sample were weighed and placed into a 
10 mL volumetric flask and then dissolved in 5 mL of methanol with 
sufficient volume to mark the boundary. Two microliters of this solution 
were then dropped onto the TLC plate using capillary pipettes. The 
standard solution and the adducted jamu solution were also dropped 
as much as 2 µL onto the same TLC plate and eluted with the selected 
mobile phase, followed by TLC-densitometry analysis. From the positive 
results of the qualitative analysis of the jamu solution containing the 
chemical compounds, quantitative analysis was performed.
Table 1: Mobile phase selection
No. Mobile phase
1. Ethyl acetate-methanol-ammonia 25% (80:15:5)
2. Methanol-ammonia 25% (100:1.5)
3. Toluene-ethyl acetate-methanol (7.5:0.5:2)
4. Aquades-methanol-glacial acetic acid (6:4:0.25)
5. Aquades-methanol-glacial acetic acid (7:3:0.25)
6. Aquades-methanol-glacial acetic acid (8:2:0.25)
7. Aquades-methanol-glacial acetic acid (9:1:0.25)
Table 2: Wavelengths of each substance based on the literature
Medicinal compound Wavelength
Glibenclamide 257 nm, 300 nm
Metformin hydrochloride 237 nm, 256 nm
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Quantitative analysis of medicinal compounds in jamu
From the samples that had a positive result in qualitative testing, 
quantitative tests were performed by weighing 350 mg of the jamu 
sample that was detected to contain added medicinal chemicals 
qualitatively 2 times; this was then placed into a 10 mL volumetric flask 
with a sufficient volume of methanol to mark the boundary.
RESULTS AND DISCUSSION
Mobile phase selection
To determine the optimal conditions for analysis, the selection of the 
best mobile phase for the analysis of glibenclamide and metformin 
hydrochloride was performed. From the experimental results, it was 
found that the mobile phase used to optimally separate glibenclamide 
and metformin hydrochloride was methanol-aquades-glacial acetic 
acid (9:1:0.25) with an Rf of 0.82 for glibenclamide and an Rf of 0.49 for 
metformin hydrochloride (Fig. 1).
Optimum wavelength determination
From the experimental results, the optimum wavelength that was 
used for the glibenclamide and metformin hydrochloride analysis 
was 237 nm, which obtained the largest area of the two compounds 
(Table 3).
Extraction system optimization
Extraction optimization was performed by comparing the area of 
the jamu adducts solution with the glibenclamide, and metformin 
hydrochloride filtered with filter paper and precipitated for 5 min. The 
best extraction optimization used consisted of precipitation for 5 min 
because an area larger than the filtered area was obtained (Table 4).
Method validation
Selectivity
For testing the selectivity, the standard solution, jamu kosong solution, 
and adducted jamu solution were spotted. The results showed that 
this method was selective because there was no interference from the 
matrix in the Rf of glibenclamide and the Rf of metformin hydrochloride.
Linearity and calibration curves
From the results of spotting the standard glibenclamide solution 
at concentrations of 500 µg/mL, 1000 µg/mL, 1500 µg/mL, 
2000 µg/mL, 2500 µg/mL, and 3500 µg/mL and the standard metformin 
hydrochloride solution at concentrations of 600 µg/mL, 800 µg/mL, 
1000 µg/mL, 1200 µg/mL, 1400 µg/mL, and 1600 µg/mL, the method 
revealed a linear relationship. The glibenclamide calibration curve 
resulted in a correlation coefficient value of 0.9998, and the metformin 
hydrochloride calibration curve resulted in a correlation coefficient 
value of 0.9981 (Figs. 2 and 3).
The r-value for glibenclamide meets the specified linearity criteria of 
being >0.999 [9]. However, the r-value for metformin hydrochloride did 
not meet this standard. This may be due to errors in standard dilution, 
Fig. 1: Chromatogram of the glibenclamide and metformin 
hydrochloride compounds
Fig. 2: Glibenclamide calibration curve
Fig. 3: Metformin hydrochloride calibration curve






Table 5: Accuracy and precision test results
Medicinal 
compounds
Concentration (µg) Recovery (%) % CV








CV: Coefficient of variation
Table 3: Optimum wavelength determination results
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errors when spotting the sample, and/or the influence of the particular 
instruments used. Nonetheless, the results are still considered 
acceptable in terms of linearity. According to Krausse (2003), the 
r-value of the linearity requirement is r≥0.98. As such, to obtain better 
linearity results, an experiment can be repeated [10].
LOD and LOQ
From the results of the LOD and LOQ tests, the LOD and LOQ values for 
glibenclamide were 49.97 µg/mL and 166.55 µg/mL, respectively. The 
LOD and LOQ values for metformin hydrochloride were 74.75 µg/mL 
and 249.25 µg/mL, respectively.
Accuracy and precision
From the results of the three concentrations (low, medium, and high) 
with six spottings, the average recovery value (Table 5) was obtained. 
The method we used met the accuracy requirements in terms of the 
recovery values being in the range of 98–102%. In addition, the 
method showed good precision, with correlation coefficient values 
below 2% [9] for glibenclamide compounds at low and moderate 
concentrations and for metformin hydrochloride compounds at low 
and high concentrations. Poor precision, as indicated by correlation 
coefficient values of more than 2%, maybe caused by errors when 
spotting the sample so that inaccurate analysis results are obtained. 
Moreover, there may also be an influence on the equipment or 
laboratory conditions. According to Riyanto (2014), variations in 
precision results can be due to random errors, such as the instability 
of instruments, variations in temperature or reagents used, and the 
diversity of techniques and different operators. To reduce these errors, 
an experiment can be repeated [11-13].
Qualitative analysis of samples
From the seven analyzed samples, four samples were positive for 
containing glibenclamide, namely, the BI, SU, SP, and LN samples; 
but there was no metformin hydrochloride found in any of the tested 
samples. This can be seen from the Rf value and its absorption compared 
with the standard and adducted samples. The resulting Rf value is close 
to the same as the Rf standard of glibenclamide (Fig. 4).
Quantitative analysis of samples
From the results obtained, glibenclamide levels in the samples exceeded 
the LOQ. At these levels, the added glibenclamide would be expected to 
provide an increased antidiabetic effect within the jamu formulation. In 
addition, the amount of glibenclamide found in the jamu BI and jamu LN 
samples was equivalent to 3.5 times the usual dosage, while that found 
in the jamu SU and jamu SP samples was equivalent to 2.9 times the 
usual dose, where the value of the usual dose of glibenclamide is 5 mg. 
It can be concluded that these jamu formulations are very dangerous 
for the treatment of diabetes because they contain medicinal chemicals 
in the form of glibenclamide greater than the standard dosage (Table 6).
CONCLUSION
The selected mobile phase used for this study was methanol-aquades-
glacial acetic acid (9:1:0.25) with an Rf value of 0.82 for glibenclamide 
and an Rf value of 0.49 for metformin hydrochloride. The best 
extraction system was obtained by precipitating the jamu for 5 min. 
The optimum wavelength for the analysis was 237 nm. Our validation 
results indicated that this method meets the requirements of linearity, 
selectivity, accuracy, and precision based on predetermined criteria.
From the seven jamu samples for diabetes, four contained 
glibenclamide, and none contained metformin hydrochloride. The 
content of glibenclamide in the samples was 4.9522% in the BI sample, 
4.1495% in the SU sample, 4.2587% in the SP sample, and 4.9412% in 
the LN sample.
Action needs to be taken by the government to monitor the misuse of 
the addition of BKO to the herbal medicines available in the market. 
This is a matter of concern for health practitioners; the government 
should educate consumers and sellers about the dangers of products 
Table 6: Quantitative sample test results
Jamu for diabetes Levels (µg/mL) Content (%) Average content (%) Weight of drug in sample packs (mg)
BI sample 1668.19 4.7602 4.9522 17.3327
1801.62 5.1442
SU sample 1454.11 4.1389 4.1495 14.5233
1461,56 4.1601
SP sample 1503.08 4.2699 4.2587 14.9055
1493.85 4.2475
LN sample 1765.03 5.0028 4.9412 17.2942
1722.87 4.8796
Fig. 4: Chromatograms of the jamu samples analyzed. (a) B1 sample; (b) SU sample; (c) SP sample; and (d) LN sample
a b
c d
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in circulation. Stricter supervision of traditional medicine distribution 
needs to be done to tackle the circulation of dangerous products in the 
community.
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